文献速递炎症性肠病

新型诊断列线图鉴别肠结核与克罗恩病的开发与验证:一项为期6年的前瞻性多中心研究

Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study.
PubMed 文献 · Am J Gastroenterol · 2019-01-01

该前瞻性多中心研究纳入6个炎症性肠病中心的310例患者,推导队列212例(143例克罗恩病、69例肠结核),验证队列98例(76例克罗恩病、22例肠结核)。基于7个差异变量建立两种回归模型及列线图,验证列线图1诊断克罗恩病的敏感度86.8%、特异度90.9%、准确率87.8%,列线图2敏感度84.2%、特异度100%、准确率87.8%。

要点

  • 基于年龄、横行溃疡、直肠受累、小肠跳跃性病变、靶征、梳齿征及IGRA或PPD构建两种列线图。
  • 验证列线图1诊断克罗恩病:敏感度86.8%、特异度90.9%、准确率87.8%。
  • 验证列线图2诊断克罗恩病:敏感度84.2%、特异度100%、准确率87.8%。

核心结论

  • 推导与验证队列识别并验证了两种高准确度且实用的诊断列线图,用于鉴别克罗恩病与肠结核,可方便地用于识别部分疑难病例,辅助临床决策。

研究设计与样本

  • 前瞻性多中心研究,从6个三级炎症性肠病中心招募310例符合条件患者。
  • 推导队列为212例连续患者(143例克罗恩病、69例肠结核),用于建立诊断方程和列线图。
  • 验证队列为98例连续患者(76例克罗恩病、22例肠结核),用于验证诊断模型。
  • 采用临床表现、实验室结果、内镜表现、CT小肠造影特征和组织学结果等7种检查方法推导诊断模型。

主要发现

  • 在总共79个参数中,8个被确定为用于建立诊断方程的有价值参数。
  • 基于7个差异变量建立两种回归模型:年龄、横行溃疡、直肠受累、小肠跳跃性病变、靶征、梳齿征,以及γ干扰素释放试验(模型1)或纯化蛋白衍生物(模型2)。
  • 验证列线图1诊断克罗恩病:特异度90.9%、敏感度86.8%、阳性预测值97.1%、阴性预测值66.7%、准确率87.8%。
  • 验证列线图2诊断克罗恩病:特异度100%、敏感度84.2%、阳性预测值100%、阴性预测值64.7%、准确率87.8%。

关键数值与推荐

  • 模型1差异变量:年龄、横行溃疡、直肠受累、小肠跳跃性病变、靶征、梳齿征、γ干扰素释放试验。
  • 模型2差异变量:年龄、横行溃疡、直肠受累、小肠跳跃性病变、靶征、梳齿征、纯化蛋白衍生物。
  • 列线图1验证诊断克罗恩病:敏感度86.8%、特异度90.9%、阳性预测值97.1%、阴性预测值66.7%、准确率87.8%。
  • 列线图2验证诊断克罗恩病:敏感度84.2%、特异度100%、阳性预测值100%、阴性预测值64.7%、准确率87.8%。

临床怎么用

  • 作者认为两种诊断列线图可方便地用于识别部分疑难的克罗恩病或肠结核病例,辅助临床决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Differentiating Crohn's disease (CD) from intestinal tuberculosis (ITB) remains a diagnostic challenge. Misdiagnosis carries potential grave implications. We aimed to develop and validate a novel diagnostic nomogram for differentiating them. METHODS: In total, 310 eligible patients were recruited from 6 tertiary inflammatory bowel disease centers. Among them, 212 consecutive patients (143 CD and 69 ITB) were used in the derivation cohort for the establishment of diagnostic equation and nomogram; 7 investigative modalities including clinical manifestations, laboratory results, endoscopic findings, computed tomography enterography features, and histology results were used to derive the diagnostic model and nomogram. Ninety-eight consecutive patients (76 CD and 22 ITB) were included for validation of the diagnostic model. RESULTS: Eight out of total 79 parameters were identified as valuable parameters used for establishing diagnostic equations. Two regression models were built based on 7 differential variables: age, transverse ulcer, rectum involvement, skipped involvement of the small bowel, target sign, comb sign, and interferon-gamma release assays (for model 1) or purified protein derivative (for model 2), respectively. Accordingly, 2 nomograms of the above 2 models were developed for clinical practical use, respectively. Further validation test verified the efficacy of the nomogram 1 with 90.9% specificity, 86.8% sensitivity, 97.1% PPV, 66.7% negative predictive value (NPV), and 87.8% accuracy for identifying CD, and the efficacy of the nomogram 2 with 100% specificity, 84.2% sensitivity, 100% positive predictive value, 64.7% NPV, and 87.8% accuracy for diagnosing CD. CONCLUSIONS: The derivation and validation cohorts identified and validated 2 highly accurate and practical diagnostic nomograms for differentiating CD from ITB. These diagnostic nomograms can be conveniently used to identify some difficult CD or ITB cases, allowing for decision-making in a clinical setting.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. He Y, Zhu Z, Chen Y, et al. Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study. Am J Gastroenterol. 2019. PMID: 30741735. doi:10.14309/ajg.0000000000000064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。